EUVIMEDEUVIMED entdecken
Crossref

Incorporation of Intracellular NanoSIMS Tracers to Oligonucleotide Conjugates via Strain Promoted Sydnone–Alkyne Cycloaddition

Loujahine Lincy-Bianchi iD, Maximilian Häfner, Cécile Becquart, Carolina Tängemo, Michael E Kurczy iD, Claire C Munier iD, Laurent Knerr iD

Bioconjugate Chemistry · 2024

DOI: 10.1021/acs.bioconjchem.4c00068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2024. Verfasst von Loujahine Lincy-Bianchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry, Research and Development, Early Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca, SE-431 83 Gothenburg,…. Hauptthemen laut MEDLINE: Alkynes, Oligonucleotides, Cycloaddition Reaction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Stiftelsen f?r Strategisk Forskning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extensive efforts have been dedicated to developing cell-specific targeting ligands that can be conjugated to therapeutic cargo, offering a promising yet still challenging strategy to deliver oligonucleotide therapeutics beyond the liver. Indeed, while the cargo and the ligand are crucial, the third component, the linker, is integral but is often overlooked. Here, we present strain-promoted sydnone-alkyne cycloaddition as a versatile linker chemistry for oligonucleotide synthesis, expanding the choices for bioconjugation of therapeutics while enabling subcellular detection of the linker and payload using nanoscale secondary ion mass spectrometry (NanoSIMS) imaging. This strategy was successfully applied to peptide and lipid ligands and profiled using the well characterized N-acetylgalactosamine (GalNAc) targeting ligand. The linker did not affect the expected activity of the conjugate and was detectable and distinguishable from the labeled cargo. Finally, this work not only offers a practical bioconjugation method but also enables the assessment of the linker's subcellular behavior, facilitating NanoSIMS imaging to monitor the three key components of therapeutic conjugates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkynesOligonucleotidesCycloaddition ReactionHumansLigandsAcetylgalactosamine

Substanzen

AlkynesOligonucleotidesLigandsAcetylgalactosamine

Autor:innen und Institutionen

  • Medicinal Chemistry, Research and Development, Early Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca, SE-431 83 Gothenburg, Sweden.
  • DMPK, Early Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, SE-431 83 Gothenburg, Sweden.
  • Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, SE-431 83 Gothenburg, Sweden.

ORCID-Profile: Loujahine Lincy-Bianchi, Michael E Kurczy, Claire C Munier, Laurent Knerr

Förderung

  • Stiftelsen f?r Strategisk Forskning

Zitieren

APA

Lincy-Bianchi, L., Häfner, M., Becquart, C., Tängemo, C., Kurczy, M. E., Munier, C. C., & Knerr, L. (2024). Incorporation of Intracellular NanoSIMS Tracers to Oligonucleotide Conjugates via Strain Promoted Sydnone–Alkyne Cycloaddition. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.4c00068

Vancouver

Lincy-Bianchi L, Häfner M, Becquart C, Tängemo C, Kurczy ME, Munier CC, et al. Incorporation of Intracellular NanoSIMS Tracers to Oligonucleotide Conjugates via Strain Promoted Sydnone–Alkyne Cycloaddition. Bioconjugate Chemistry. 2024. doi:10.1021/acs.bioconjchem.4c00068

BibTeX
@article{LincyBianchi2024,
  author = {Lincy-Bianchi, Loujahine and Häfner, Maximilian and Becquart, Cécile and Tängemo, Carolina and Kurczy, Michael E and Munier, Claire C and Knerr, Laurent},
  title = {Incorporation of Intracellular NanoSIMS Tracers to Oligonucleotide Conjugates via Strain Promoted Sydnone–Alkyne Cycloaddition},
  journal = {Bioconjugate Chemistry},
  year = {2024},
  doi = {10.1021/acs.bioconjchem.4c00068}
}
Kostenlos starten →